[Asia Economy Reporter Park Junyi] Jinwon Life Science announced on the 13th that it has decided to issue convertible bond rights for anonymous interest-bearing unsecured private convertible bonds worth approximately 11.7 billion KRW for operating funds.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing